Additional European Equity News
AstraZeneca (AZN LN) - Koselugo recommended for EU approval. In other news, Tezspire is recommended for approval in the EU for CRSwNP. (Newswires)
Canal+ (CAN LN) - Co. acquires a majority stake in Multichoice. (Newswires)
Fugro (FUR NA) - Withdraws FY guidance. Still expect H2 to show a "notable improvement" vs H1, the prev. guided 20% revenue growth is "no longer realistic". "A wide range of projects has been affected – with most experiencing postponements into 2026 and some being descoped – resulting in an estimated revenue impact of around EUR 100mln". (Fugro) Seen opening -5% to -10%
Adecco (ADEN SW) upgraded to Outperform from Market Perform at Bernstein
ASML (ASML NA) upgraded to Overweight from Equal Weight; PT raised to EUR 950 (prev. EUR 600)
22 Sep 2025 - 07:05- EquitiesEU Research- Source: Newsquawk
Subscribe Now to Newsquawk
Click here for a 1 week free trial
Newsquawk provides audio news and commentary for over 15,000professional traders and brokers worldwide. Services include:
- Real-time audio coverage from 0630 to 2200 London time plus Asia-Pac 2200 to 1000 London time
- Teams of analysts covering equities, fixed income, FX, energy, and metals markets
- Real-time scrolling news service with instant analysis
- Daily and weekly pre-market research and calendars
- Video updates covering near-term key risk events & primary trading themes
- One-to-one chat with our expert analysts